eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all . Please read our guidelines before submitting your own eLetter.
Research ArticleNEUROSCIENCE
Awake functional MRI detects neural circuit dysfunction in a mouse model of autism
- View ORCID ProfileTomokazu Tsurugizawa1,*,
- Kota Tamada2,
- View ORCID ProfileNobukazu Ono3,
- Sachise Karakawa3,
- Yuko Kodama3,
- View ORCID ProfileClement Debacker1,
- Junichi Hata2,4,
- View ORCID ProfileHideyuki Okano2,4,
- Akihiko Kitamura3,
- Andrew Zalesky5 and
- View ORCID ProfileToru Takumi2,6,*
- 1NeuroSpin, Commissariat à l’Energie Atomique et aux Energies Alternatives, CEA Saclay, Gif-sur-Yvette 91191, France.
- 2RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
- 3Institute for Innovation, Ajinomoto Co. Inc., Kawasaki 210-8681, Japan.
- 4Department of Physiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8585, Japan.
- 5Melbourne Neuropsychiatry Centre and Department of Biomedical Engineering, University of Melbourne, Victoria 3010, Australia.
- 6Department of Physiology and Cell Biology, Kobe University School of Medicine, Chuo, Kobe 650-0017, Japan.
- ↵*Corresponding author. Email: tsurugizawa{at}gmail.com (T.Ts.); takumit{at}med.kobe-u.ac.jp (T.Ta.)
See allHide authors and affiliations
Science Advances 05 Feb 2020:
Vol. 6, no. 6, eaav4520
DOI: 10.1126/sciadv.aav4520
Vol. 6, no. 6, eaav4520
DOI: 10.1126/sciadv.aav4520
Tomokazu Tsurugizawa
1NeuroSpin, Commissariat à l’Energie Atomique et aux Energies Alternatives, CEA Saclay, Gif-sur-Yvette 91191, France.
Kota Tamada
2RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
Nobukazu Ono
3Institute for Innovation, Ajinomoto Co. Inc., Kawasaki 210-8681, Japan.
Sachise Karakawa
3Institute for Innovation, Ajinomoto Co. Inc., Kawasaki 210-8681, Japan.
Yuko Kodama
3Institute for Innovation, Ajinomoto Co. Inc., Kawasaki 210-8681, Japan.
Clement Debacker
1NeuroSpin, Commissariat à l’Energie Atomique et aux Energies Alternatives, CEA Saclay, Gif-sur-Yvette 91191, France.
Junichi Hata
2RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
4Department of Physiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8585, Japan.
Hideyuki Okano
2RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
4Department of Physiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8585, Japan.
Akihiko Kitamura
3Institute for Innovation, Ajinomoto Co. Inc., Kawasaki 210-8681, Japan.
Andrew Zalesky
5Melbourne Neuropsychiatry Centre and Department of Biomedical Engineering, University of Melbourne, Victoria 3010, Australia.
Toru Takumi
2RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
6Department of Physiology and Cell Biology, Kobe University School of Medicine, Chuo, Kobe 650-0017, Japan.
Submit a Response to This Article
No eLetters have been published for this article.